Dry Eye Syndrome Description During Cataract Surgery, With Multimodal Analysis of the Ocular Surface

NCT03923244 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-04-24

No results posted yet for this study

Summary

The main objective is to describe the characteristics of dry eye syndrome before and after surgery at one month of cataract surgery, using a multimodal analysis of the ocular surface.

The secondary objectives are to evaluate:

* Predictive factors of dry eye syndrome during cataract surgery:
* The characteristics of dry eye syndrome
* Implications for the patient's quality of life

Conditions

  • Dry Eye Syndrome
  • Ocular Surface Disease

Interventions

DIAGNOSTIC_TEST

OSDI survey

Normal patient consultation schedule for cataract surgery with: * Preoperative appointment scheduled for the patient * Post-operative appointment 1 month before surgery No additional appointments. After geting consent and during the two consultations: * Completion of a quality of life survey by the patient. Collection of the patient's history and general and ophthalmological treatments. Questionnaire of 12 items on quality of life to be completed. For each question, the patient must answer on the frequency of the discomfort felt, from "never" to "all the time". * An analysis of the ocular surface is performed by a non-invasive and non-contact device for 4 minutes. This consists of taking different photographs of the eye and eyelids, allowing each to study a part of the tears. * Schirmer test is performed, consisting of applying the end of a small strip of blotting paper behind the lower eyelid and examining the strip after 5 minutes.

Sponsors & Collaborators

  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • frédéric Chiambaretta · University Hospital, Clermont-Ferrand

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2020-03-06
Completion
2020-03-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03923244 on ClinicalTrials.gov